Trial intelligence / Profile preview

Effect of 0.9% sodium chloride on kidney function and vasoactive markers during primary hip arthrosis surgery

2014-004742-10Phase 4Completed

Sponsor
Regional Hospital Holstebro
Start
Nov 2014
Countries
1
01

Overview

Phase 4 trial of sodium chloride in primary coxarthrosis (2 arms), sponsored by Regional Hospital Holstebro. Primary endpoint: Neutrophil gelatinase-associated lipocalin (NGAL). Started Nov 2014; status: completed.

02

Drugs

sodium chloride
03

Conditions

primary coxarthrosis

Beyond the preview

Go deeper on 2014-004742-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-004742-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call